CRISPR-Cas9 System: Opportunities and Concerns

S. K. Vasiliou, E. P. Diamandis, G. M. Church, H. T. Greely, F. Baylis, C. Thompson, G. Schmitt-Ulms
  • Clinical Chemistry, August 2016, AACC
  • DOI: 10.1373/clinchem.2016.263186

The authors haven't finished explaining this publication. If you are the author, sign in to claim or explain your work.

Read Publication

http://dx.doi.org/10.1373/clinchem.2016.263186

The following have contributed to this page: Francoise Baylis

In partnership with: